Singular Genomics Systems, Inc. (OMIC) Tops Q4 EPS by 14c

Singular Genomics Systems, Inc. (NASDAQ: OMIC) reported Q4 EPS of ($0.29), $0.14 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $770 thousand versus the consensus estimate of $790.18 thousand.

For earnings history and earnings-related data on Singular Genomics Systems, Inc. (OMIC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c